Treatment Outcome in Patients with Mycobacterium abscessus Complex Lung Disease: The Impact of Tigecycline and Amikacin

Background: The contemporary guidelines have recommended multiple antimicrobial therapies along with oral macrolides for the treatment of Mycobacterium abscessus complex lung disease (MABC-LD). However, there is little evidence supporting the parenteral tigecycline-containing regimens against MABC-L...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jeng-How, Wang, Ping-Huai, Pan, Sheng-Wei, Wei, Yu-Feng, Chen, Chung-Yu, Lee, Ho-Sheng, Shu, Chin-Chung, Wu, Ting-Shu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137771/
https://www.ncbi.nlm.nih.gov/pubmed/35625215
http://dx.doi.org/10.3390/antibiotics11050571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137771/
https://www.ncbi.nlm.nih.gov/pubmed/35625215
http://dx.doi.org/10.3390/antibiotics11050571

Ejemplares similares